Cysteinyl-leukotriene receptor antagonist montelukast decreases blood–brain barrier permeability but does not prevent oedema formation in traumatic brain injury

Abstract

The present study suggests that montelukast may have beneficial effects against TBI-induced oxidative stress of the brain.